Japan Pharmacist Group Renews Opposition to Off-Year Re-Pricing in FY2021

May 22, 2020
The Japan Pharmaceutical Association (JPA) on May 20 submitted its written request to the health minister for a second emergency package being formulated by the government to cushion the economic impact of COVID-19, reiterating its opposition against so-called “off-year” re-pricing...read more